Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $351,462 | 160 | 72.3% |
| Travel and Lodging | $80,476 | 306 | 16.6% |
| Food and Beverage | $26,700 | 604 | 5.5% |
| Consulting Fee | $26,620 | 17 | 5.5% |
| Education | $573.37 | 16 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Ascendis Pharma Inc | $140,804 | 285 | $0 (2024) |
| ABBVIE INC. | $104,733 | 154 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $86,558 | 67 | $0 (2024) |
| Kyowa Kirin, Inc. | $59,499 | 109 | $0 (2024) |
| Novo Nordisk Inc | $51,312 | 114 | $0 (2024) |
| Azurity Pharmaceuticals, Inc. | $10,815 | 7 | $0 (2024) |
| TOLMAR Pharmaceuticals, Inc. | $7,923 | 15 | $0 (2022) |
| Endo Pharmaceuticals Inc. | $7,372 | 27 | $0 (2023) |
| Insulet Corporation | $3,681 | 185 | $0 (2024) |
| Ferring Pharmaceuticals Inc. | $3,660 | 16 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $234,902 | 315 | SANOFI-AVENTIS U.S. LLC ($63,330) |
| 2023 | $132,400 | 258 | Ascendis Pharma Inc ($53,801) |
| 2022 | $47,178 | 169 | Ascendis Pharma, Inc. ($37,760) |
| 2021 | $4,796 | 32 | AbbVie Inc. ($3,480) |
| 2020 | $10,743 | 26 | AbbVie Inc. ($10,438) |
| 2019 | $17,938 | 70 | AbbVie, Inc. ($11,235) |
| 2018 | $20,776 | 114 | Novo Nordisk Inc ($9,675) |
| 2017 | $17,097 | 119 | Novo Nordisk Inc ($6,032) |
All Payment Transactions
1,103 individual payment records from CMS Open Payments — Page 1 of 45
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Kyowa Kirin, Inc. | Crysvita (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,760.00 | General |
| Category: fibroblast growth factor 23 (FGF23) blocking antibody. | ||||||
| 12/23/2024 | BETA BIONICS, INC. | iLet Bionic Pancreas (Device), iLet Bionic Pancreas, iLet Bionic Pancreas | Food and Beverage | In-kind items and services | $146.97 | General |
| Category: Automated insulin delivery system | ||||||
| 12/23/2024 | Kyowa Kirin, Inc. | Crysvita (Drug) | Travel and Lodging | Cash or cash equivalent | $97.75 | General |
| Category: fibroblast growth factor 23 (FGF23) blocking antibody. | ||||||
| 12/23/2024 | Kyowa Kirin, Inc. | Crysvita (Drug) | Travel and Lodging | Cash or cash equivalent | $49.95 | General |
| Category: fibroblast growth factor 23 (FGF23) blocking antibody. | ||||||
| 12/23/2024 | Kyowa Kirin, Inc. | Crysvita (Drug) | Travel and Lodging | Cash or cash equivalent | $36.61 | General |
| Category: fibroblast growth factor 23 (FGF23) blocking antibody. | ||||||
| 12/23/2024 | BETA BIONICS, INC. | iLet Bionic Pancreas (Device), iLet Bionic Pancreas, iLet Bionic Pancreas | Food and Beverage | In-kind items and services | $20.36 | General |
| Category: Automated insulin delivery system | ||||||
| 12/23/2024 | Kyowa Kirin, Inc. | Crysvita (Drug) | Travel and Lodging | Cash or cash equivalent | $16.00 | General |
| Category: fibroblast growth factor 23 (FGF23) blocking antibody. | ||||||
| 12/23/2024 | Kyowa Kirin, Inc. | Crysvita (Drug) | Food and Beverage | Cash or cash equivalent | $12.18 | General |
| Category: fibroblast growth factor 23 (FGF23) blocking antibody. | ||||||
| 12/18/2024 | Novo Nordisk Inc | Sogroya (Biological) | Food and Beverage | In-kind items and services | $25.92 | General |
| Category: Growth Hormone | ||||||
| 12/13/2024 | Kyowa Kirin, Inc. | — | Travel and Lodging | In-kind items and services | $571.96 | General |
| 12/12/2024 | Kyowa Kirin, Inc. | — | Travel and Lodging | In-kind items and services | $285.82 | General |
| 12/10/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,866.00 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 12/03/2024 | Ascendis Pharma Inc | Skytrofa (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,285.00 | General |
| Category: Endocrinology | ||||||
| 12/03/2024 | PFIZER INC. | GENOTROPIN (Drug), NGENLA | Food and Beverage | In-kind items and services | $16.90 | General |
| Category: ENDOCRINE DISEASE | ||||||
| 12/02/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,531.00 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 12/02/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $105.05 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 12/02/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Travel and Lodging | Cash or cash equivalent | $83.08 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 11/27/2024 | Kyowa Kirin, Inc. | Crysvita (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,760.00 | General |
| Category: fibroblast growth factor 23 (FGF23) blocking antibody. | ||||||
| 11/26/2024 | Kyowa Kirin, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,760.00 | General |
| 11/26/2024 | Kyowa Kirin, Inc. | — | Food and Beverage | Cash or cash equivalent | $88.55 | General |
| 11/26/2024 | Kyowa Kirin, Inc. | — | Travel and Lodging | Cash or cash equivalent | $73.85 | General |
| 11/26/2024 | Kyowa Kirin, Inc. | — | Travel and Lodging | Cash or cash equivalent | $67.49 | General |
| 11/26/2024 | Kyowa Kirin, Inc. | — | Travel and Lodging | Cash or cash equivalent | $67.10 | General |
| 11/26/2024 | Kyowa Kirin, Inc. | — | Food and Beverage | Cash or cash equivalent | $50.00 | General |
| 11/26/2024 | Kyowa Kirin, Inc. | — | Food and Beverage | Cash or cash equivalent | $30.78 | General |
About Dr. Joshua Yang, MD
Dr. Joshua Yang, MD is a Pediatric Endocrinology healthcare provider based in Orlando, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1588677876.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Joshua Yang, MD has received a total of $485,831 in payments from pharmaceutical and medical device companies, with $234,902 received in 2024. These payments were reported across 1,103 transactions from 37 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($351,462).
Practice Information
- Specialty Pediatric Endocrinology
- Location Orlando, FL
- Active Since 08/15/2006
- Last Updated 03/07/2023
- Taxonomy Code 2080P0205X
- Entity Type Individual
- NPI Number 1588677876
Products in Payments
- SKYTROFA (Drug) $91,560
- LUPRON DEPOT (Drug) $77,252
- TZIELD (Biological) $72,461
- Skytrofa (Drug) $49,244
- Crysvita (Drug) $46,177
- Sogroya (Biological) $27,771
- Norditropin (Drug) $17,599
- Lupron Depot (Drug) $11,235
- Lupron (Drug) $10,142
- FENSOLVI (Drug) $8,469
- SUPPRELIN LA (Drug) $7,309
- Norditropin (Biological) $5,537
- Omnipod (Device) $3,681
- ZOMACTON (Drug) $3,660
- STRENSIQ (Biological) $2,363
- TRIPTODUR (Drug) $1,803
- FIASP (Drug) $1,511
- t-slim insulin pump (Device) $807.94
- iLet Bionic Pancreas (Device) $590.19
- Dexcom G6 Transmitter (Medical Supply) $419.61
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatric Endocrinology Doctors in Orlando
Dr. Matthew Benson, M.d, M.D
Pediatric Endocrinology — Payments: $92,545
Dr. Mauri Carakushansky, Md, MD
Pediatric Endocrinology — Payments: $5,454
Dr. Jennifer Villar, Md, MD
Pediatric Endocrinology — Payments: $5,235
Dr. Paul Desrosiers, Md, MD
Pediatric Endocrinology — Payments: $4,078
Dr. Richard Banks, Md, MD
Pediatric Endocrinology — Payments: $3,734
Dr. Akaluck Thatayatikom, Md, MD
Pediatric Endocrinology — Payments: $3,383